We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.49M
1-Year Est. Return 18.57%
This Fund
S&P 500
This Quarter Est. Return
-50.58%
1 Year Est. Return
-18.57%
3 Year Est. Return
-38.34%
5 Year Est. Return
-87.14%
10 Year Est. Return
AUM
$1.45M
AUM Growth
-$1.66M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRX icon
1
TScan Therapeutics
TCRX
$55.3M
$630K 43.36%
630,000
BRNS
2
Barinthus Biotherapeutics
BRNS
$24.5M
$450K 30.95%
642,204
HOWL icon
3
Werewolf Therapeutics
HOWL
$17.5M
$373K 25.69%
589,102

Similar funds

DC Funds's Q4 2025 Portfolio in Review

As of Q4 2025, DC Funds held 3 positions worth $1.45M, down 53% from $3.11M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 0%. DC Funds opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds's ten largest holdings make up 100% of its $1.45M portfolio in Q4 2025.
  • DC Funds opened 0 new positions and closed 0 in Q4 2025.
  • DC Funds's portfolio value fell 53% quarter-over-quarter to $1.45M.

Based on DC Funds's 13F filing for Q4 2025, filed 13 Feb 2026.